Furthermore, the expressions of angiotensin II type 1 and 2 receptor, Ki67, KEAP-1 were found to decrease with an increase in angiotensin-converting enzyme 2 (ACE2) expressions in insulin resistance and type 2 diabetic rats after receiving the esculetin therapy. The gene discussed is ACE2; the disease is type 2 diabetes mellitus.